These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31058798)

  • 21. Vital signs: awareness and treatment of uncontrolled hypertension among adults--United States, 2003-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Sep; 61():703-9. PubMed ID: 22951452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Home blood pressure monitoring and hypertension status among US adults: the National Health and Nutrition Examination Survey (NHANES), 2009-2010.
    Ostchega Y; Berman L; Hughes JP; Chen TC; Chiappa MM
    Am J Hypertens; 2013 Sep; 26(9):1086-92. PubMed ID: 23604493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.
    Howard VJ; Tanner RM; Anderson A; Irvin MR; Calhoun DA; Lackland DT; Oparil S; Muntner P
    Am J Med; 2015 Jul; 128(7):707-14.e2. PubMed ID: 25770032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States.
    Ezzati M; Oza S; Danaei G; Murray CJ
    Circulation; 2008 Feb; 117(7):905-14. PubMed ID: 18268146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Apparent Treatment-Resistant Hypertension in the United States.
    Carey RM; Sakhuja S; Calhoun DA; Whelton PK; Muntner P
    Hypertension; 2019 Feb; 73(2):424-431. PubMed ID: 30580690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the prevalence and treatment of hypertension in two populations in the United States: masters swimmers versus the NHANES population.
    Guthrie SK; Erickson SR; Lau MS
    J Sports Sci; 2013; 31(9):930-5. PubMed ID: 23305384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood Pressure Control Among Non-Hispanic Black Adults Is Lower Than Non-Hispanic White Adults Despite Similar Treatment With Antihypertensive Medication: NHANES 2013-2018.
    Hayes DK; Jackson SL; Li Y; Wozniak G; Tsipas S; Hong Y; Thompson-Paul AM; Wall HK; Gillespie C; Egan BM; Ritchey MD; Loustalot F
    Am J Hypertens; 2022 Jun; 35(6):514-525. PubMed ID: 35380626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment options for resistant hypertension: from pseudoresistant to refractory hypertension].
    Versmissen J; Hendriks K; van den Meiracker AH; Kappers MH
    Ned Tijdschr Geneeskd; 2015; 160():A9937. PubMed ID: 27142503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.
    Thomas G; Xie D; Chen HY; Anderson AH; Appel LJ; Bodana S; Brecklin CS; Drawz P; Flack JM; Miller ER; Steigerwalt SP; Townsend RR; Weir MR; Wright JT; Rahman M;
    Hypertension; 2016 Feb; 67(2):387-96. PubMed ID: 26711738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertension control and antihypertensive therapy in patients with chronic kidney disease.
    Unni S; White K; Goodman M; Ye X; Mavros P; Bash LD; Brixner D
    Am J Hypertens; 2015 Jun; 28(6):814-22. PubMed ID: 25421796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization patterns of antihypertensive drugs among the chronic kidney disease population in the United States: a cross-sectional analysis of the national health and nutrition examination survey.
    Sonawane KB; Qian J; Hansen RA
    Clin Ther; 2015 Jan; 37(1):188-96. PubMed ID: 25524390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States.
    Lu Y; Wang P; Zhou T; Lu J; Spatz ES; Nasir K; Jiang L; Krumholz HM
    J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29374046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
    Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive drug therapy and survival by treatment status in a national survey.
    Havlik RJ; LaCroix AZ; Kleinman JC; Ingram DD; Harris T; Cornoni-Huntley J
    Hypertension; 1989 May; 13(5 Suppl):I28-32. PubMed ID: 2577459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991.
    Burt VL; Cutler JA; Higgins M; Horan MJ; Labarthe D; Whelton P; Brown C; Roccella EJ
    Hypertension; 1995 Jul; 26(1):60-9. PubMed ID: 7607734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Comparison of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline and the 2017 American Diabetes Association Diabetes and Hypertension Position Statement for U.S. Adults With Diabetes.
    Muntner P; Whelton PK; Woodward M; Carey RM
    Diabetes Care; 2018 Nov; 41(11):2322-2329. PubMed ID: 30150235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevalence of true resistant hypertension among uncontrolled hypertensive patients referred to a tertiary health care center].
    Henine N; Kichou B; Kichou L; Benbouabdellah M; Boubchir MA; Madiou A; Hammouche A; Saheb B
    Ann Cardiol Angeiol (Paris); 2016 Jun; 65(3):191-6. PubMed ID: 27180567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refractory versus resistant hypertension.
    Siddiqui M; Calhoun DA
    Curr Opin Nephrol Hypertens; 2017 Jan; 26(1):14-19. PubMed ID: 27798457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES).
    Kaczmarski KR; Sozio SM; Chen J; Sang Y; Shafi T
    BMC Nephrol; 2019 Apr; 20(1):138. PubMed ID: 31023262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.